Boston Scientific (BSX) Stock Price, News & Analysis

Company Overview

Boston Scientific is a medical technology company that develops, manufactures and markets devices used in minimally invasive procedures across a range of medical specialties. Founded in 1979, the company is headquartered in Marlborough, Massachusetts.

Its products support areas including cardiovascular care, endoscopy, urology and neuromodulation. They include catheter-based devices and therapies for conditions affecting the heart and blood vessels, as well as devices used in diagnostic and therapeutic procedures involving the digestive and urinary systems.

Boston Scientific serves healthcare providers and patients around the world. Its portfolio is organized around cardiovascular and MedSurg businesses, reflecting the range of specialties and procedures its products support.

Key Stats

• Today's Range: $43.87 to $45.82
• 50-Day Range: $41.55 to $48.40
• 52-Week Range: $39.57 to $105.65
• Volume: 17.78 million shs
• Average Volume: 20.31 million shs
• Market Capitalization: $65.47 billion
• P/E Ratio: 14.01
• Dividend Yield: N/A
• Price Target: $61.43
• Consensus Rating: Moderate Buy

Boston Scientific Stock Analysis - MarketRank™

Boston Scientific scored higher than 88% of companies evaluated by MarketBeat, and ranked 33rd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Boston Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.65, and is based on 1 strong buy rating, 20 buy ratings, 8 hold ratings, and 2 sell ratings.

Upside Potential

Boston Scientific has a consensus price target of $61.43, representing about 36.0% upside from its current price of $45.17.

Amount of Analyst Coverage

Boston Scientific has been the subject of 20 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: -2.52%

Earnings Growth

Earnings for Boston Scientific are expected to decrease by -2.52% in the coming year, from $3.17 to $3.09 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Boston Scientific is 14.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.24.

Price to Earnings Ratio vs. Sector

The P/E ratio of Boston Scientific is 14.01, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.15.

Price to Earnings Growth Ratio

Boston Scientific has a PEG Ratio of 1.32. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Boston Scientific has a P/B Ratio of 2.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.43% of the float of Boston Scientific has been sold short.

Short Interest Ratio / Days to Cover

Boston Scientific has a short interest ratio ("days to cover") of 1.65, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Boston Scientific has recently decreased by 13.74%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Boston Scientific does not currently pay a dividend.

Dividend Growth

Boston Scientific does not have a long track record of dividend growth.

News and Social Media

• Score: 3.9 / 5
• News Sentiment: 1.18

News Sentiment

Boston Scientific has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for Boston Scientific this week, compared to 8 articles on an average week.

Search Interest

Only 61 people have searched for BSX on MarketBeat in the last 30 days. This is a decrease of -22% compared to the previous 30 days.

MarketBeat Follows

17 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 70% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Boston Scientific insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.34% of the stock of Boston Scientific is held by insiders.

Percentage Held by Institutions

89.07% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 10/28/2026
• Today: 11/11/2026
• Stifel 2026 Healthcare Conference 2026: 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:BSX
• CIK: 885725
• Web: www.bostonscientific.com
• Phone: (508) 683-4000
• Fax: 508-683-5675
• Employees: 59,000
• Year Founded: 1979

Price Target and Rating

• Average Price Target for Boston Scientific: $61.43
• High Price Target: $118.00
• Low Price Target: $44.00
• Potential Upside/Downside: +36.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.65
• Research Coverage: 31 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.36
• Trailing P/E Ratio: 14.01
• Forward P/E Ratio: 14.62
• P/E Growth: 1.32
• Net Income: $2.90 billion
• Net Margins: 16.62%
• Pretax Margin: 17.35%
• Return on Equity: 18.61%
• Return on Assets: 10.58%

Debt

• Debt-to-Equity Ratio: 0.42
• Current Ratio: 1.36
• Quick Ratio: 0.81

Sales & Book Value

• Annual Sales: $20.07 billion
• Price / Sales: 3.26
• Cash Flow: $4.08 per share
• Price / Cash Flow: 11.08
• Book Value: $17.85 per share
• Price / Book: 2.53

Miscellaneous

• Outstanding Shares: 1,449,470,000
• Free Float: 1,444,545,000
• Market Cap: $65.47 billion
• Optionable: Optionable
• Beta: 0.60